Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06821594 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Role of Intralesional Combined Injection of Furosemide and Digoxin in Cutaneous Warts at Tertiary Care Hospital in Karachi.

StatusEnrolling by Invitation
PhaseEarly Phase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 12, 2025 (before its estimated August 30, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
Identify the effects of combined intralesional furosemide 20mg/2ml and digoxin 0.5mg/2ml in cutaneous warts given weekly are rather safe and effective treatment for cutaneous warts, focusing on their effectiveness and safety, at a tertiary care hospital in Karachi, Pakistan.
Trial Details
NCT Number NCT06821594
Lead Sponsor Jinnah Postgraduate Medical Centre
Conditions
(from sponsor)		 Cutaneous Warts
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov